PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Perindopril erbumine
Presentation Product Chemical substance Chapter Items dispensed
Perindopril erbumine 8mg tablets
0205051M0AAAFAF
Perindopril erbumine Perindopril erbumine Cardiovascular System 261,976
Perindopril erbumine 4mg tablets
0205051M0AAABAB
Perindopril erbumine Perindopril erbumine Cardiovascular System 221,811
Perindopril erbumine 2mg tablets
0205051M0AAAAAA
Perindopril erbumine Perindopril erbumine Cardiovascular System 147,983
Perindopril erbumine 4mg/5ml oral solution
0205051M0AAAKAK
Perindopril erbumine Perindopril erbumine Cardiovascular System 56
Perindopril erbumine 4mg/5ml oral suspension
0205051M0AAALAL
Perindopril erbumine Perindopril erbumine Cardiovascular System 36
Perindopril erbumine 8mg/5ml oral liquid
0205051M0AAAHAH
Perindopril erbumine Perindopril erbumine Cardiovascular System 7
Coversyl 2mg tablets
0205051M0BBAAAA
Coversyl Perindopril erbumine Cardiovascular System No data available
Coversyl 4mg tablets
0205051M0BBABAB
Coversyl Perindopril erbumine Cardiovascular System No data available
Coversyl 8mg tablets
0205051M0BBACAF
Coversyl Perindopril erbumine Cardiovascular System No data available
Perindopril erbumine 1mg/5ml oral liquid
0205051M0AAACAC
Perindopril erbumine Perindopril erbumine Cardiovascular System No data available
Perindopril erbumine 2mg oral powder sachets
0205051M0AAAJAJ
Perindopril erbumine Perindopril erbumine Cardiovascular System No data available
Perindopril erbumine 2mg/5ml oral suspension
0205051M0AAADAD
Perindopril erbumine Perindopril erbumine Cardiovascular System No data available
Perindopril erbumine 3mg/5ml oral solution
0205051M0AAAMAM
Perindopril erbumine Perindopril erbumine Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.